Mark Sieczkarek
2016
In 2016, Mark Sieczkarek earned a total compensation of $2.1M as Chairman of the Board and CEO at NovaBay Pharmaceuticals, a 1,957% increase compared to previous year.
Compensation breakdown
| Bonus | $240,000 |
|---|---|
| Option Awards | $1,424,410 |
| Salary | $300,000 |
| Stock Awards | $126,188 |
| Other | $13,500 |
| Total | $2,104,098 |
Sieczkarek received $1.4M in option awards, accounting for 68% of the total pay in 2016.
Sieczkarek also received $240K in bonus, $300K in salary, $126.2K in stock awards and $13.5K in other compensation.
Rankings
In 2016, Mark Sieczkarek's compensation ranked 4,657th out of 14,075 executives tracked by ExecPay. In other words, Sieczkarek earned more than 66.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,657 out of 14,075 | 67th |
Division Manufacturing | 1,653 out of 5,489 | 70th |
Major group Chemicals And Allied Products | 514 out of 1,895 | 73rd |
Industry group Drugs | 379 out of 1,538 | 75th |
Industry Pharmaceutical Preparations | 299 out of 1,176 | 75th |
Source: SEC filing on April 18, 2018.
Sieczkarek's colleagues
We found two more compensation records of executives who worked with Mark Sieczkarek at NovaBay Pharmaceuticals in 2016.